TRYPTYR for Dry Eye Syndrome
What You Need to Know Before You Apply
What is the purpose of this trial?
The purpose of this research study is to determine the effectiveness of TRYPTYR as a treatment for Dry Eye Disease. The primary efficacy variable is change from baseline in the Ocular Surface Disease Index (OSDI) at week 2. The co-primary efficacy variables are change from baseline in the National Eye Institute (NEI) scale of the cornea and NEI scale of the conjunctiva at 1 month (the third visit).
Who Is on the Research Team?
Giacomina Massaro-Giordano, MD
Principal Investigator
NYU Langone Health
Are You a Good Fit for This Trial?
This trial is for people diagnosed with dry eye disease. Participants should not have other serious eye conditions or recent eye surgeries, and must meet the study's health requirements.Inclusion Criteria
Exclusion Criteria
What Are the Treatments Tested in This Trial?
Interventions
- TRYPTYR (Acoltremon ophthalmic solution 0.003%)
Trial Overview
The study is testing TRYPTYR (Acoltremon ophthalmic solution 0.003%), an eye drop, to see if it helps improve symptoms of dry eye disease over a few weeks.
How Is the Trial Designed?
1
Treatment groups
Experimental Treatment
Participants will be treated with the TRYPTYR drug for one month
Find a Clinic Near You
Who Is Running the Clinical Trial?
NYU Langone Health
Lead Sponsor
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.